Navigation Links
Human Pheromone Sciences Enters Into Agreement to Reposition and Promote its Natural Attraction(R) Brand
Date:9/12/2007

SAN JOSE, Calif., Sept. 12 /PRNewswire-FirstCall/ -- Human Pheromone Sciences, Inc. (OTC Bulletin Board: EROX) ("HPS" or "the Company") today announced the signing of an exclusive Agency Agreement with Brand Intelligence Group, Inc. ("BIG"), to reposition and promote the Company's Natural Attraction(R) brand, which contains its proprietary and patented human pheromone technology.

Under the terms of the Agreement, HPS and BIG will work together to develop a comprehensive program to repackage, reposition and promote the Natural Attraction brand, in order to capitalize on the potential strength of the trademark and its underlying technology.

In commenting on the Agreement, an HPS spokesperson indicated that the Company has been primarily focused on developing long-term relationships with leaders in the consumer products arena to incorporate the Company's mood-enhancing technology in products marketed and sold by such corporate partners. "While our primary focus has been successful in attracting industry leaders to incorporate our technology in their products, we have not focused our Natural Attraction line," said Bill Horgan, CEO, of the Company. In August of last year, the Company entered into a License Agreement with a Johnson & Johnson subsidiary, and most recently signed a non-exclusive agreement with Schwarkf and Henkel for several hair care lines. The Company noted that additional product introductions by Licensees are imminent.

BIG is a New York City-based consortium of branding, communication, licensing and marketing firms specializing in fragrance, fashion, lifestyle and luxury products. Co-presidents, Louis Iacovelli and Deborah Moses, are recognized experts in positioning and repositioning brands. Their collective client experience in beauty and fragrance include L'Oreal, Estee Lauder, Givenchy Fragrance, Coty Prestige, Dolce & Gabbana, Vera Wang, Gianni Versace, Yves Saint Laurent, Moschino, Joseph Abboud, Smash Box, Urban Decay, Bare Escentuals and Be Fine.

Human Pheromone Sciences, Inc. is a technology-based company, whose proof-of concept products included prestige-priced fragrances and toiletries and environmental products sold under the Natural Attraction(R), REALM(R), innerREALM(R) and EROX(R) trademarks. These products contain mood-enhancing compounds, whose efficacy has been validated at leading universities around the world, and whose use is covered under United States and foreign patents. The Company is also involved in research and product development efforts on new compounds that have been previously identified as stimulating the emotional centers of the human brain. Further information is available on line at http://www.erox.com.

The statements in this news release may contain forward-looking statements that involve risks and uncertainties that could cause results to differ from predicted results. Further information on factors that could affect the Company's results is detailed in the Company's annual report to shareholders on Form 10-KSB for the year ended December 31, 2006, and Form 10-QSB for the quarters ended March 31, 2007 and June 30, 2007, as filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements.


'/>"/>
SOURCE Human Pheromone Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Human Primary Preadipocytes and Differentiated Adipocytes
2. Low Abundance cDNA Cloned Using Stratagenes Human Universal cDNA Library
3. Control RT-PCR Primers for Human Gene Transcripts with Varying Abundance
4. New Mammalian Expression Vectors Employ Stable, High-Level Fluorescence Humanized Renilla GFP Reporter
5. Human Universal cDNA Library Array I
6. Map and Link Human Genetic Disorders with SSLP Analysis
7. RT-PCR Primer Sets for Human and Mouse Mismatch Repair Genes
8. Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells
9. Fluorescence-Based Single-Tube Assays to Rapidly Detect Human Gene Mutations
10. Improve Lipid- or Calcium Phosphate-Mediated Transfection of Human Dermal Fibroblasts
11. Sequence-Validated and Expression-Tested Human cDNA in a Dual Expression Vector
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... AMRI, a global contract ... to improve patient outcomes and quality of life, will now be offering its ... attributed to new regulatory requirements for all new drug products, including the finalization ...
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit ... 7th and 8th June 2018 in San Francisco, CA. The Summit brings together current ... several distinguished CEOs, board directors and government officials from around the world to address ...
(Date:10/11/2017)... TX (PRWEB) , ... October 11, 2017 , ... ... August compared the implantation and pregnancy rates in frozen and fresh in ... contribution of progesterone and maternal age to IVF success. , After comparing the ...
(Date:10/10/2017)... ... 2017 , ... Dr. Bob Harman, founder and CEO of VetStem Biopharma, ... The event entitled “Stem Cells and Their Regenerative Powers,” was held on ... DVM, MPVM was joined by two human doctors: Peter B. Hanson, M.D., Chief of ...
Breaking Biology Technology:
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/30/2017)... 30, 2017 Trends, opportunities and forecast in ... by technology (fingerprint, AFIS, iris recognition, facial recognition, hand ... by end use industry (government and law enforcement, commercial ... banking, and others), and by region ( North ... Asia Pacific , and the Rest of ...
(Date:3/27/2017)... , March 27, 2017  Catholic Health Services ... Management Systems Society (HIMSS) Analytics for achieving Stage ... Model sm . In addition, CHS previously earned ... hospitals using an electronic medical record (EMR). ... high level of EMR usage in an outpatient ...
Breaking Biology News(10 mins):